Table 5.
Author | Patients | Isotope | Complete remission | Reduction | No change | expansion | Tumor control | Visual impairment |
---|---|---|---|---|---|---|---|---|
Voges et al. (1997) | 62 | Y 90 | 35/78 | 27/78 | 12/78 | 4/78 | 10 years OS | 4/62 |
78 C | Rhe 186 | Solid: 31% | ||||||
P 32 | Cystic: 64% | |||||||
Blackburn et al. (1999) | 6 | Y 90 | 0 | 6 | 1 | 2 | n.a. | 1/5 |
9 C | ||||||||
Hasegawa et al. (2004) | 41 | P 32 | 7 | 24 | 5 | 5 | 10 years: 70% | 3/40 (RT induced) |
41 C | Solid comp.: 32% increase | |||||||
Derrey et al. (2008) | 39 | Rhe 186 | 17 | 17 | 5 | 5 | n.a. | 3/39 |
44 C |
C, cysts; Y 90, Yttrium 90; Rhe 186, Rhenium 186; P 32, Phosphorus 32; OS, overall survival.